Next Article in Journal
A Role of Newly Found Auxiliary Site in Phospholipase A1 from Thai Banded Tiger Wasp (Vespa affinis) in Its Enzymatic Enhancement: In Silico Homology Modeling and Molecular Dynamics Insights
Next Article in Special Issue
Diversity of the Genomes and Neurotoxins of Strains of Clostridium botulinum Group I and Clostridium sporogenes Associated with Foodborne, Infant and Wound Botulism
Previous Article in Journal
Purification and Characterization of the Pink-Floyd Drillipeptide, a Bioactive Venom Peptide from Clavus davidgilmouri (Gastropoda: Conoidea: Drilliidae)
Previous Article in Special Issue
Pan-Genomic Analysis of Clostridium botulinum Group II (Non-Proteolytic C. botulinum) Associated with Foodborne Botulism and Isolated from the Environment
Open AccessReview

Foodborne Botulism: Clinical Diagnosis and Medical Treatment

Poison Control Centre and National Toxicology Information Centre—Toxicology Unit Istituti Clinici Scientifici Maugeri IRCCS, Maugeri Hospital, Pavia Via Salvatore Maugeri, 10, 27100 Pavia, Italy
Author to whom correspondence should be addressed.
Toxins 2020, 12(8), 509;
Received: 14 July 2020 / Revised: 4 August 2020 / Accepted: 6 August 2020 / Published: 7 August 2020
(This article belongs to the Special Issue New Challenges in Foodborne Botulism Outbreaks)
Botulinum neurotoxins (BoNTs) produced by Clostridia species are the most potent identified natural toxins. Classically, the toxic neurological syndrome is characterized by an (afebrile) acute symmetric descending flaccid paralysis. The most know typical clinical syndrome of botulism refers to the foodborne form. All different forms are characterized by the same symptoms, caused by toxin-induced neuromuscular paralysis. The diagnosis of botulism is essentially clinical, as well as the decision to apply the specific antidotal treatment. The role of the laboratory is mandatory to confirm the clinical suspicion in relation to regulatory agencies, to identify the BoNTs involved and the source of intoxication. The laboratory diagnosis of foodborne botulism is based on the detection of BoNTs in clinical specimens/food samples and the isolation of BoNT from stools. Foodborne botulism intoxication is often underdiagnosed; the initial symptoms can be confused with more common clinical conditions (i.e., stroke, myasthenia gravis, Guillain–Barré syndrome—Miller–Fisher variant, Eaton–Lambert syndrome, tick paralysis and shellfish or tetrodotoxin poisoning). The treatment includes procedures for decontamination, antidote administration and, when required, support of respiratory function; few differences are related to the different way of exposure. View Full-Text
Keywords: botulism; diagnosis; treatment; food; toxicity; Poison Center; poisoning; intoxication; rehabilitation botulism; diagnosis; treatment; food; toxicity; Poison Center; poisoning; intoxication; rehabilitation
MDPI and ACS Style

Lonati, D.; Schicchi, A.; Crevani, M.; Buscaglia, E.; Scaravaggi, G.; Maida, F.; Cirronis, M.; Petrolini, V.M.; Locatelli, C.A. Foodborne Botulism: Clinical Diagnosis and Medical Treatment. Toxins 2020, 12, 509.

AMA Style

Lonati D, Schicchi A, Crevani M, Buscaglia E, Scaravaggi G, Maida F, Cirronis M, Petrolini VM, Locatelli CA. Foodborne Botulism: Clinical Diagnosis and Medical Treatment. Toxins. 2020; 12(8):509.

Chicago/Turabian Style

Lonati, Davide; Schicchi, Azzurra; Crevani, Marta; Buscaglia, Eleonora; Scaravaggi, Giulia; Maida, Francesca; Cirronis, Marco; Petrolini, Valeria M.; Locatelli, Carlo A. 2020. "Foodborne Botulism: Clinical Diagnosis and Medical Treatment" Toxins 12, no. 8: 509.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop